CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Wedbush Initiates Benitec Biopharma at Outperform With $16 Price Target

Positive
AI Analysis

Summary

Wedbush initiated coverage of Benitec Biopharma with an Outperform rating and a $16 price target.

Importance:3/10
Sentiment:
0.70
analyst_coverageequity_researchprice_target
Related Companies

Read the original article

Published by yahoo_finance on July 28, 2026 10:46 AM

Read Original